Document Detail

Development of a validated UPLC-qTOF-MS Method for the determination of curcuminoids and their pharmacokinetic study in mice.
Jump to Full Text
MedLine Citation:
PMID:  23356399     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: A specific and sensitive UPLC-qTOF-MS/MS method has been developed for the simultaneous determination of curcuminoids. These Curcuminoids comprises of curcumin, a principal curcuminoid and other two namely, demethoxycurcumin, and bisdemethoxycurcumin obtained from rhizomes of Curcuma longa an ancient Indian curry spice turmeric, family (Zingiberaceae).
METHODS: These analytes were separated on a reverse phase C18 column by using a mobile phase of acetonitrile: 5% acetonitrile in water with 0.07% acetic acid (75:25 v/v), flow rate of 100 μL/min was maintained. The qTOF-MS was operated under multiple reaction monitoring (MRM) mode using electro-spray ionization (ESI) technique with positive ion polarity. The major product ions in the positive mode for curcuminoids were at m/z 369.1066, 339.1023 and 309.0214 respectively. The recovery of the analytes from mouse plasma was optimized using solid phase extraction technique.
RESULTS: The total run time was 5 min and the peaks of the compounds, bisdemethoxycurcumin, demethoxycurcumin and curcumin occurred at 2.06, 2.23 and 2.40 min respectively. The calibration curves of bisdemethoxycurcumin, demethoxycurcumin and curcumin were linear over the concentration range of 2-1000 ng/mL (r2, 0.9951), 2-1000 ng/mL (r2, 0.9970) and 2-1000 ng/mL (r2, 0.9906) respectively.Intra-assay and inter-assay accuracy in terms of % bias for curcumin was in between -7.95to +6.21, and -7.03 to + 6.34; for demethoxycurcumin was -6.72 to +6.34, and -7.86 to +6.74 and for bisdesmetoxycurcumin was -8.23 to +6.37 and -8.47 to +7.81. The lower limit of quantitation for curcumin, demethoxycurcumin and bisdemethoxycurcumin was 2.0 ng/mL. Analytes were stable under various conditions (in autosampler, during freeze-thaw, at room temperature, and under deep-freeze conditions). This validated method was used during pharmacokinetic studies of curcumin in the mouse plasma.
CONCLUSIONS: A specific, accurate and precise UPLC-qTOF-MS/MS method for the determination of curcumin, demethoxycurcumin and bisdemethoxycurcumin both individually and simultaneously was optimized.
Authors:
Mahendra K Verma; Ishtiyaq A Najar; Manoj K Tikoo; Gurdarshan Singh; Devinder K Gupta; Rajneesh Anand; Ravi K Khajuria; Subhash C Sharma; Rakesh K Johri
Related Documents :
24484549 - Detection of huanglongbing disease using differential mobility spectrometry.
24636559 - Combining the quechers approach and clean-up by immunoaffinity column for the analysis ...
2490749 - Flow injection extraction applied to dissolution rate studies of felodipine tablets.
23400289 - Determination of salicylic acid in human serum and urine samples by high-performance li...
23777619 - Determination of an unstable pentapeptide, monocyte locomotion inhibitory factor, in do...
24247549 - Screen-printed electrode-based electrochemical detector coupled with in-situ ionic-liqu...
8173129 - Effect of preparation method and storage on rifampin concentration in suspensions.
24878969 - Measuring masses of large biomolecules and bioparticles using mass spectrometric techni...
3201529 - Evaluation of chromatographic and kit immunoassay techniques for the measurement of the...
Publication Detail:
Type:  Journal Article     Date:  2013-01-29
Journal Detail:
Title:  Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences     Volume:  21     ISSN:  1560-8115     ISO Abbreviation:  Daru     Publication Date:  2013  
Date Detail:
Created Date:  2013-03-20     Completed Date:  2013-03-21     Revised Date:  2013-04-18    
Medline Journal Info:
Nlm Unique ID:  101125969     Medline TA:  Daru     Country:  England    
Other Details:
Languages:  eng     Pagination:  11     Citation Subset:  -    
Affiliation:
PK/PD and Toxicology Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu, India. mkvermadr@yahoo.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Daru
Journal ID (iso-abbrev): Daru
ISSN: 1560-8115
ISSN: 2008-2231
Publisher: BioMed Central
Article Information
Download PDF
Copyright ©2013 Verma et al; licensee BioMed Central Ltd.
open-access:
Received Day: 20 Month: 10 Year: 2012
Accepted Day: 20 Month: 1 Year: 2013
collection publication date: Year: 2013
Electronic publication date: Day: 29 Month: 1 Year: 2013
Volume: 21 Issue: 1
First Page: 11 Last Page: 11
PubMed Id: 23356399
ID: 3599580
Publisher Id: 2008-2231-21-11
DOI: 10.1186/2008-2231-21-11

Development of a validated UPLC-qTOF-MS Method for the determination of curcuminoids and their pharmacokinetic study in mice
Mahendra K Verma2 Email: mkvermadr@yahoo.com
Ishtiyaq A Najar1 Email: ishtiyaq0786@gmail.com
Manoj K Tikoo1 Email: mktikoo@iiim.ac.in
Gurdarshan Singh1 Email: gdsingh@iiim.ac.in
Devinder K Gupta3 Email: dkgupta@iiim.ac.in
Rajneesh Anand2 Email: ranand@iiim.ac.in
Ravi K Khajuria2 Email: rkhajuria@iiim.ac.in
Subhash C Sharma1 Email: scsharma@iiim.ac.in
Rakesh K Johri1 Email: rkjohri@iiim.ac.in
1PK/PD and Toxicology Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu, India
2Analytical Chemistry Division (Instrumentation), CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu, India
3Biorganic Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu, India

Background

Curcuma longa L. (Zingiberaceae) is a coloring agent, has been found to be a rich source of phenolic compounds, namely, curcuminoids (2-5%) [1]. C. longa consists of a mixture of three naturally occurring curcuminoids. Curcumin the principal curcuminoid (about 80%) and other two curcuminoids are demethoxycurcumin (about 12%) and bisdemethoxycurcumin (about 8%).

Curcuminoids are recognized for their broad spectrum biological activities and have been generally regarded as safe (GRAS) in foods or pharmaceuticals. Curcumin is widely used for coloring of foods like pickles and snacks.

Many pharmacological properties have been attributed to curcuminoids including anti-inflammatory and hepatoprotective activities [2], antioxidant and cholekinetic activities [3,4] and anti-protease activity [5,6]. In addition, apoptosis have been shown to induce in human cancer cells by the curcuminoids [7] and act as a chemopreventive agents for major types of cancer, including the stomach, lung, breast, prostate, colon and duodenal cancers, as well as leukemias [8-12] and display neuroprotective effects [13]. Curcumin has also been reported a more potent free radical scavenger than vitamin E [14].

It is also known for its potential use of curcumin in the treatment of infections such as human immunodeficiency virus (HIV) is also reported [15].

Quantification of the active metabolite, THC in plasma and urine by HPLC method has also been reported [16] and simultaneous quantification of diferuloylmethane and its metabolites in biological matrices has been reported by LC/MS/MS [17].

Hence, due to the immense biological importance [18] of curcumin and its analogues, there is a need for effective, rapid and more sensitive methods to monitor curcuminoids. Various HPLC methods are available in literature for determination of curcuminoids [19-29]. HPLC-MS methods also reported to provide quantitation of curcuminoids [30-32].

In recent times UPLC with qTof-MS is widely considered analytical technique for better quality data in terms of increased detection limits, and chromatographic resolution with greater sensitivity. This paper presents (i) a method for the simultaneous determination of curcuminoids by UPLC–qTOF-MS, and (ii) a pharmacokinetic study of curcumin in mice.


Methods
Material and methods

Curcumin, demethoxycurcumin and bis-demethoxycurcumin used as standards were isolated from the rhizomes of C. longa by the method already reported in literature. The isolated curcuminoids were identified on the basis of NMR and Mass spectral data. The purity of standards was >99%. All solvents/chemicals used were of HPLC grade and obtained from E-Merck, Mumbai, India. The HPLC grade water was obtained from a Water Purification System (Synergy UV, Millipore, USA).

Instrumentation

A UPLC-qTOF-MS system (Synapt, Waters, USA, equipped with MassLynx acquisition software, version 4.1) was used. Experimental conditions were column, C-18 (50 × 2.1 mm); particle size, 1.7 μm; (Acquity, BEH); flow rate, 100 μL/min; mobile phase, acetonitrile: 5% acetonitrile in water with 0.07% acetic acid (75: 25 v/v), injection volume, 5 μL. The analyte infusion experiments were performed using an in-built syringe pump. A mass spectrometer with ESI interface was used for MS/MS analysis. ESI parameters were as follows: capillary voltage, 2.7 kV for positive mode; source temperature, 83°C; desolvation temperature, 200°C; cone gas flow, 50 L/h and desolvation gas flow, 550 L/h. The multiple reaction monitoring (MRM) mode was used to monitor the transition of curcumin m/z 391.0864 [M+Na], 369.1066 (M+H) to 285.0912, demethoxycurcumin at 339.1023 (M+H) to 255.0848 and of bisdemethoxycurcumin at m/z 309.0968 [M+H] to 225.0790.

Preparation of reference, standard and quality control solutions

Reference solutions of curcumin (C) (stock I), demethoxycurcumin (DMC), (stock II) and bisdemethoxycurcumin (BDMC) (stock III) were prepared by weighing 5 mg of each compound. The quantities were transferred to 5 mL volumetric flasks, dissolved and diluted suitably with HPLC grade methanol. All the reference solutions (1 mg/mL) were covered with aluminium foil and sealed with paraffin film to avoid photodegradation and loss due to evaporation. Stock I, stock II and stoke III were mixed together, and diluted suitably with methanol. A 50-uL of this solution was used to spike blank mouse plasma samples (450 uL) to achieve 8 calibration standards (CAL STD) containing curcuminoids combination. CAL STD-1: curcuminoids, 2 ng/mL; CAL STD-2: 5 ng/mL each; CAL STD-3: 10 ng/mL each; CAL STD-4: 50 ng/mL each; CAL STD-5: 100 ng/mL each; CAL STD-6: 200 ng/mL each; CAL STD-7: 500 ng/mL each; and CAL STD-8: 1000 ng/mL each. Three quality control (QC) standards (LQC: 2 ng/mL; MQC: 450 ng/mL; HQC 900 ng/mL each of curcuminoids) were prepared and used to spike blank mouse plasma.

Method validation procedures

The analytical method was validated to meet the acceptance criteria as per guidelines of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The specificity of the method was established by comparing blank plasma samples with those spiked with the analytes to find out interference from endogenous components. The CAL STD solutions were utilized for establishment of linearity and range (linear least-squares regression with a weighting index of 1/x). The precision and accuracy parameters were ascertained in LLOQ, LQC, MQC, and HQC samples (7 replicates each in 3 sets) on the same day and on 3 consecutive days. The intra-assay and inter-assay accuracy (% bias) of the method was determined from mean measured concentrations and nominal concentrations as follows: % bias = [(mean measured conc.−nominal conc.)/nominal conc.]×100. The intra-assay and inter-assay precision (% relative standard deviation or RSD) of the method was calculated from mean measured concentrations as follows: % RSD = (SD of mean measured conc./mean measured conc.)×100. The stability of analytes in plasma was investigated under following conditions: (a) 1 month storage at deep freeze (−80°C); (b) 3 consecutive freeze–thaw cycles from −20°C to room temperature; (c) 24 h storage at room temperature; and (d) short-term stability (of processed samples) at 10°C for 24 h in autosampler. After specified storage conditions, samples were processed and analyzed. The matrix effect was investigated by post extraction spike method. Peak area (A) of the analyte in spiked blank plasma with a known concentration (MQC) was compared with the corresponding peak area (B) obtained by direct injection of standard in the mobile phase. The ratio (A/B×100) is defined as the matrix effect.

Sample preparation

The curcumin (C), demethoxycurcumin (DMC), and bisdemethoxycurcumin (BDMC) were recovered simultaneously from plasma using solid phase extraction (SPE) technique involving semi-automated vacuum chamber and vacuum pump (Supelco, USA). The various steps involved in the recovery procedure were: (a) conditioning of SPE cartridge (C18, 3 mL capacity, 100 mg bed, Samprep-Ranbaxy, Mumbai, India) with 1.0mLmethanol, followed by 1.0 mL water, (b) loading of diluted (1:4, v/v) plasma samples (1.0 mL) onto cartridge and drying under positive pressure, and (c) samples were washed with 2 mL of water followed by elution with 2 mL of methanol. The eluants were carefully collected in 2.0 mL capacity glass vials for direct analysis in UPLC–qTOF-MS system.

Experimental animals

Swiss mice (22–30 g) were obtained from the Animal House of this Institute, and kept in regulated environmental conditions (temperature: 25 ± 2°C, humidity: 60 ± 5%, 12 h dark/light cycle). Animals were fed on standard pelleted diet (Ashirwad Industries, Chandigarh, India) and water was provided ad libitum. Animal experiments were approved by Institutional Ethics Committee. Animals were fasted overnight before the experiment and segregated into different groups for the sample collections at different time intervals. All these animals were administered with curcumin (100 mg/kg, p.o.). Blood samples were collected in pre-heparinized glass tubes at different time intervals post dosing (0–24 hr). Blood samples were centrifuged (5000 rpm; 10 min at 20°C) to separate the plasma.

Pharmacokinetics

Concentration-time curves for Concentration–time curves were established for curcumin from the treated mice and used for the determination of pharmacokinetic parameters such as peak plasma concentration (Cmax), peak time (Tmax), extent of absorption (AUC), half-life (t1/2), clearance (Cl), and volume of distribution (Vd) by a non-compartmental analysis using PK Solutions Version 2.0; Summit Research Services, USA.


Results
UPLC–qTOF-MS/MS analysis

Optimum chromatographic separation of curcuminoids was achieved by acetonitrile: 5% acetonitrile in water with 0.07% acetic acid (75:25 v/v). Flow rate of 100 μL/min was maintained. All the analytes were added simultaneously in the samples and the resulting chromatograms showed a retention time of 2.06, 2.23 and 2.40 min for bisdemethoxycurcumin, demethoxycurcumin and curcumin respectively (Figure  1A, B & C). A full scan in positive ion mode was used for all the analytes. During direct infusion, the mass spectra of the major product ions in the positive mode for bisdemethoxycurcumin m/z 309.0968 [M+H]+ to the product ion 225.0790 (Figure  2A) demethoxycurcumin m/z 339.1023 (M+H) to 255.0848 (Figure  2B) and of curcumin m/z 391.0864 [M+Na], 369.1066 (M+H) to 285.0912 (Figure  2C).

Method validation
Specificity

The method was found to be specific: Extracted blank plasma when compared with plasma samples spiked with curcuminoids did not show any interference at the respective retention times of each analyte.

Linearity and range

The calibration curves of bisdemethoxycurcumin, demethoxycurcumin and curcumin were linear over the concentration range of 2–1000 ng/mL (r2, 0.9951), 2–1000 ng/mL (r2, 0.9970) and 2-1000 ng/mL (r2, 0.9906) respectively.

Accuracy and precision

The combined recovery of curcumin, demethoxycurcumin and bisdemethoxycurcumin was carried out in LLQC, LQC, MQC and HQC samples. The recovery (mean ± S.E.) of curcumin was 93.2% ± 4.1 (from LLQC), 95.6% ± 3.9 (from LQC), 96.2% ± 3.2 (from MQC), and 93.4% ± 2.9 (from HQC). The recovery (mean ± S.E.) of demethoxycurcumin was 92.8% ± 4.3 (from LLQC) 94.3% ± 3.8 (from LQC), 91.7% ± 3.3 (from MQC), and 91.5% ± 2.7 (from HQC). The recovery (mean ± S.E.) of bisdemethoxycurcumin was 89.9% ± 6.2 (from LLQC), 93.3% ± 5.2 (from LQC), 91.6% ± 3.2 (from MQC), and 90.5% ± 2.6 (from HQC). The intra-assay and inter-assay accuracy in terms of % bias were given in Table  1.

Intra- assay and inter-assay precision (% RSD) were presented in Table  2.

The accuracy and precision of the method were within the acceptable limits of ±15%.

Lower limit of quantitation (LLOQ)

The LLOQ for curcumin, demethoxycurcumin and bisdemethoxycurcumin were 2.0 ng/mL.

Stability

The stability of the analytes in plasma was investigated in LQC and HQC samples. The recoveries of the analytes after one month (storage stability), after 1, 2 and 3 cycles of freeze–thaw and after 24 h (stability at room temp.) relative to that at time zero are summarized in Table  3.

Matrix effect

The matrix effect (A/B×100) for Curcumin was 96.78% (% RSD: 3.14; n = 5), and for DMC it was 97.31% (% RSD: 4.05; n = 5) and for BDMC it was 96.13% (% RSD: 3.89; n=5) Percent RSD < 5 suggested that the method was free from matrix effect.

Pharmacokinetics

Concentration vs. time profile of Curcumin and pharmacokinetic parameters (Figure  3, Table  4). Each time point is mean±SE (n = 6). For details refer Section 1.6.


Discussion

Three curcuminoids were used as a standard in the present study showed separate peaks in the extracted ion chromatogram (EIC) at 2.06, 2.23 and 2.40 min for bisdemethoxycurcumin demethoxycurcumin and Curcumin respectively. The bisdemethoxycurcumin demethoxycurcumin and Curcumin, were also appeared in the total ion chromatogram TIC. These three curcuminods were also shown together in the ESI spectra (Figure  4).

A method for the determination of curcumin, demethoxycurcumin and bisdemethoxycurcumin by UPLC-qTOF-MS/MS has not been reported, prior to this investigation, in which curcuminoids have been quantified on the basis of their major fragment. The major product ions observed in the positive ion ESI spectra curcumin m/z 391.0864 [M+Na], 369.1066 (M+H) to 285.0912, demethoxycurcumin at 339.1023 (M+H) to 255.0848 and of bisdemethoxycurcumin at m/z 309.0214 [M+H]+ to the production 225.0790. The quantification of the analytes was achieved by using MRM which makes the proposed method most acceptable.

Previously reported HPLC-UV methods for the quantification and determination of curcuminoids have several disadvantages, such as unsatisfactory separation times (needs more analysis time), poor resolution and complicated solvent mixtures with gradient elution. These methods are not selective, rapid, so a time-consuming pretreatment of a sample, or complicate gradient elution is required.

We have developed a simple, reliable and an isocratic UPLC-qTOF-MS/MS method which require only binary solvent system containing water and acetonitrile. This method has shown high degree of simplicity, accuracy, sensitivity, reproducibility and also provides short analysis time (5 min.). In the proposed method the linearity was in the range between 2 ng/mL to 1000 ng/mL which makes the method most suitable for the trace quantification of analytes. This method can also be used for the quantification of individual curcuminoids for routine analysis.

The method was validated in terms of specificity, accuracy, precision, sensitivity and stability of the analytes, and utilized for the determination of curcumin, demethoxycurcumin and bisdemethoxrcurcumin either individually or simultaneously in plasma (mice). After oral administration curcumin could be quantified only up to 24 h of sampling time. A pharmacokinetic parameters from plasma concentration-time data usually involves the maximum (peak) plasma drug concentrations (Cmax) and the area under the plasma concentration –time curve (AUC). The plasma drug concentration increases with the rate of absorption; therefore the most widely used general index of absorption is Cmax. AUC is another reliable measure for the extent of absorption. It is directly proportional to the total amount of unchanged drug that reaches systemic circulation.


Conclusions

A specific, accurate and precise UPLC-qTOF-MS/MS method for the determination of curcumin, demethoxycurcumin and bisdemethoxycurcumin both individually and simultaneously was optimized. Pharmacokinetic study of curcumin was carried out by using this validated method.


Competing interests

The authors declare that they have no competing interests.


Authors’ contributions

MK, SC and RK conceived and designed the study and prepared the manuscript. MK, SC, IA, GD and MT carried out all the experimental work and statistical analysis and helped to draft the manuscript. MK carried out the UPLC –Q-TOF-MS studies, DK isolated the compounds by using column chromatography studies and compounds were characterized by MK, DK, RA and RKK. All authors read and approved the final manuscript.


Acknowledgements

Authors are thankful to the Director, CSIR-IIIM, Jammu for providing necessary facility for the work.


References
Inoue K,Nomura C,Ito S,Nagatsu A,Hino T,Oka H,Purification of curcumin, demethoxycurcumin, and bisdemethoxycurcumin by high- speed countercurrent chromatographyJ Agric Food ChemYear: 2008569328933610.1021/jf801815n18826228
Lukita-Atmadja W,Ito Y,Baker GL,McCuskey RS,Effect of curcuminoids as anti-inflammatory agents on the hepatic microvascular response to endotoxinShockYear: 20021739940310.1097/00024382-200205000-0001012022761
Masuda T,Hidaka K,Shimohara A,Maekawa T,Takeda Y,Yamaguchi H,Chemical studies on antioxidant mechanism of curcuminoid: analysis of radical reaction products from curcuminJ Agric Food ChemYear: 199947717710.1021/jf980534810563852
Rasyid A,Rahman AR,Jaalam K,Lelo A,Effect of different curcumin dosages on human gall bladderAsia Pac J Clin NutrYear: 20021131431810.1046/j.1440-6047.2002.00296.x12495265
Nishigaki I,Kuttan R,Oku H,Ashoori F,Abe H,Yagi K,Suppressive effect of curcumin on lipid peroxidation induced in rats by carbon tetrachloride or 60Co-irradiationJ Clin Biochem NutrYear: 199213232910.3164/jcbn.13.23
Sui Z,Salto R,Li J,Craik C,De Montellano PRO,Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexesBioorg Med ChemYear: 1993141542210.1016/S0968-0896(00)82152-58087563
Choudhuri T,Pal S,Agwarwal ML,Das T,Sa G,Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax inductionFEBS LettYear: 200251233434010.1016/S0014-5793(02)02292-511852106
Kelloff GJ,Crowell JA,Steele VE,Lubet RA,Malone WA,Boone CW,Kopelovich L,Hawk ET,Lieberman R,Lawrence JA,Ali I,Viner JL,Sigman CC,Progress in cancer chemoprevention: development of diet-derived chemopreventive agentsJ NutrYear: 2000130467S471S10721931
Shao ZM,Shen ZZ,Liu CH,Sartippour MR,Go VL,Heber D,Nguyen M,Curcumin exerts multiple suppressive effects on human breast carcinoma cellsInt J CancerYear: 20029823424010.1002/ijc.1018311857414
Duvoix A,Blasius R,Delhalle S,Schnekenburger M,Morceau F,Henry E,Dicato M,Diederich M,Chemopreventive and therapeutic effects of curcuminCancer LettYear: 200522318119010.1016/j.canlet.2004.09.04115896452
Kawamori T,Lubet R,Steele VE,Kelloff GJ,Kaskey RB,Rao CV,Reddy BS,Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancerCancer ResYear: 1999595976019973206
Kanai M,Imaizumi A,Otsuka Y,Sasaki H,Hashiguchi M,Tsujiko K,Matsumoto S,Ishiguro H,Chiba T,Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteersCancer Chemother PharmacolYear: 201269657010.1007/s00280-011-1673-121603867
Lee HS,Jung KK,Cho JY,Rhee MH,Hong S,Kwon M,Kim SH,Kang SY,Neuroprotective effect of curcumin is mainly mediated by blockade of microglial cell activationPharmazieYear: 20076293794218214347
Zhao BL,Li XJ,He RG,Cheng SJ,Xin WJ,Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicalsCell BiophysYear: 1989141751852472207
Ammon HP,Wahl MA,Pharmacology of Curcuma longaPlanta MedYear: 1991571710.1055/s-2006-9600042062949
Pan MH,Huang TM,Lin JK,Biotransformation of curcumin through reduction and glucuronidation in miceDrug Metab DisposYear: 19992748649410101144
Heath DD,Pruitt MA,Brenner DE,Begum AN,Frautschy SA,Rock CL,Tetrahydrocurcumin in plasma and urine: Quantitation by high performance liquid ChromatographyJ Chromatogr B, Analyt Technol Biomed Life SciYear: 200582420621210.1016/j.jchromb.2005.07.026
Esatbeyoglu T,Huebbe P,Ernst IMA,Chin D,Wagner AE,Rimbach G,Curcumin—from molecule to biological functionAngew Chem Int EdYear: 2012515308533210.1002/anie.201107724
Bos R,Windono T,Woerdenbag HJ,Boersma YL,Koulman A,Kayser O,HPLC-photodiode array detection analysis of curcuminoids in Curcuma species indigenous to IndonesiaPhytochem AnalYear: 20071811812210.1002/pca.95917439012
Jadhav BK,Mahadik KR,Paradkar AR,Development and validation of improved reversed phase-HPLC method for simultaneous determination of curcumin, demethoxycurcumin and bis-demethoxycurcuminChromatographiaYear: 20076548348810.1365/s10337-006-0164-8
Jayaprakasha GK,Rao LJM,Sakariah KK,Improve HPLC method for the determination of curcumin, demethoxycurcumin, and bisdemethoxycurcuminJ Agric Food ChemYear: 2002503668367210.1021/jf025506a12059141
Khurana A,Ho CT,High-performance liquid chromatography analysis of curcuminoids and their photo-oxidative decomposition compound in C. longa LJ Liq ChromatogrYear: 19981122952304
Li R,Xiang C,Ye M,Li HF,Zhang X,Guo D,Qualitative and quantitative analysis of curcuminoids in herbal medicines derived from Curcuma speciesFood ChemYear: 18902011126
Naidu MM,Shyamala BN,Manjunatha JR,Sulochanamma G,Srinivas P,Simple HPLC method for resolution of curcuminoids with antioxidant potentialJ Food SciYear: 200974312318
Scotter MJ,Synthesis and chemical characterisation of curcuminoid colouring principles for their potential use as HPLC standards for the determination of curcumin colour in foodsFood Sci TechYear: 20094213451351
Taylor SJ,McDowell IJ,Determination of the curcuminoid Pigments in turmeric (Curcuma domestica Val) by reversed-phase high performance liquid chromatographyChromatographiaYear: 199234737710.1007/BF02290463
Tonnesen HH,Karlsen J,High-performance liquid chromatography of curcumin and related compoundsJ ChromatogrYear: 1983259367371
Wichitnithad W,Jongaroonngamsang N,Pummangura S,Rojsitthisak P,A simple isocratic HPLC method for the simultaneous determination of curcuminoids in commercial turmeric extractsPhytochem AnalYear: 20092031431910.1002/pca.112919402187
Xie Y,Jiang ZH,Zhou H,Cai X,Wong YF,Liu ZQ,Bian ZX,Xu HX,Liu L,Combinative method using HPLC quantitative and qualitative analysis for quality consistency assessment of a herbal medicinal preparationJ Pharm Biomed AnalYear: 20074320421210.1016/j.jpba.2006.07.00816920317
He XG,Lin LZ,Lian LZ,Lindenmaier M,Liquid chromatography electrospray mass spectrometric analysis of curcuminoids and sesquiterpenoids in turmeric (Curcuma longa)J Chromatogr AYear: 199881812713210.1016/S0021-9673(98)00540-8
Liu R,Zhang J,Liang M,Zhang W,Yan S,Lin M,Simultaneous analysis of eight bioactive compounds in Danning tablet by HPLC-ESI-MS and HPLC-UVJ Pharm Biomed AnalYear: 2007431007101210.1016/j.jpba.2006.09.03117079108
Jiang H,Timmermann BN,Gang DR,Use of liquid chromatography–electrospray ionization tandem mass spectrometry to identify diarylheptanoids in turmeric (C. longa L.) rhizomeJ Chromatogr AYear: 20061111213110.1016/j.chroma.2006.01.10316490201

Figures

[Figure ID: F1]
Figure 1 

Typical UPLC-qTOF-MS/MS chromatograms showing Curcuminoids. 1 A. Extracted ion chromatogram (EIC) of bisdemethoxycurcumin. 1 B. Extracted ion chromatogram (EIC) of demethoxycurcumin. 1 C. Extracted ion chromatogram (EIC) of curcumin. 1 D. Total ion chromatogram (TIC) of Curcuminoids.



[Figure ID: F2]
Figure 2 

2 A - Product ion spectra of bisdemethoxrcurcumin showing fragmentation transitions. 2 B - Product ion spectra of demethoxrcurcumin showing fragmentation transitions. 2 C - Product ion spectra of curcumin showing fragmentation transitions.



[Figure ID: F3]
Figure 3 

Plasma concn. vs. time curves of curcumin (100 mg/kg, p.o).



[Figure ID: F4]
Figure 4 

The mass spectrum of curcuminoids in combination showing the molecular ion peaks, chemical structures and molecular weights.



Tables
[TableWrap ID: T1] Table 1 

Accuracy (% bias) data


Compound
Nominal conc. (ng/mL)
Intra -assay
Inter-assay
    Set 1 Set 2 Set 3 Set 1 Set 2 Set 3
Curcumin
2
+5.81
−7.95
−7.02
+6.34
+5.38
−5.86
6
+5.98
−6.29
+6.21
−7.03
+4.39
+5.39
450
−4.23
+5.09
− 3.86
−5.61
+5.94
4.79
900
+3.84
−4.72
−5.37
+4.67
−5.38
−5.01
DMC
2
+6.34
−5.81
−6.62
+6.74
+5.89
−5.06
6
+5.68
−6.72
+6.04
−7.86
+4.95
+6.21
450
−4.73
+5.89
− 5.31
−5.88
+5.04
−5.86
900
+5.09
−4.38
−5.66
+5.17
−6.72
−4.71
BDMC
2
+6.37
−8.23
−7.91
+6.73
+7.81
−6.54
6
+ 5.28
−6.98
+7.41
−8.47
+6.39
+5.86
450
−6.29
+5.73
− 6.06
−6.80
+5.68
− 6.89
  900 +5.87 −6.32 −6.98 +5.69 −4.63 − 7.08

[TableWrap ID: T2] Table 2 

Precision (% RSD) data


Compound
Nominal conc. (ng/mL)
Intra -assay
Inter-assay
    Set 1 Set 2 Set 3 Set 1 Set 2 Set 3
Curcumin
2
8.31
7.34
7.93
8.59
6.57
7.81
6
6.38
7.51
8.76
7.77
8.32
6.68
450
4.68
6.39
5.51
5.31
6.07
5.85
900
2.94
3.89
4.79
5.28
4.79
5.53
DMC
2
9.27
8.86
9.65
9.85
8.89
9.41
6
7.41
6.09
7.38
7.05
6.59
9.77
450
5.24
4.84
6.07
6.18
7.04
6.17
900
4.41
4.79
6.06
4.69
5.31
4.99
BDMC
2
11.37
9.98
10.57
9.23
10.88
10.54
6
8.68
7.98
9.07
9.35
8.47
9.86
450
5.86
7.79
8.95
6.32
5.89
5.49
  900 4.46 5.32 5.48 3.69 4.79 6.24

[TableWrap ID: T3] Table 3 

Stability data


Condition
CMN
DMC
BDMC
  LQC HQC LQC HQC LQC HQC
Recovery (ng) after storage (−80°C)
5.92 ±0.141
888.974 ± 1.876
5.90 ±0.161
885±1.948
5.71±0.209
874 ±2.375
 0 month
 
 
 
 
 
 
 1 month
5.81±0.165 (98.14%)
853.41 ± 1.451 (95.99%)
5.78±0.178 (97.97%)
861±1.381 (97.29%)
5.57±0.393 (97.55%)
845 ±3.058 (96.68%)
Recovery (ng) after freeze thaw cycles
5.92 ± 0.141
888.974 ± 1.876
5.90± 0.161
885±1.948
5.71±0.209
874 ±2.375
 Cycle 0
5.82±0.186
878.413±
5.84±0.181
869±1.768
5.65±0.219
870 ±2.435
 Cycle 1
(98.31%)
1.381 (98.81%)
(98.98%)
(98.19%)
(98.94%)
(99.54%)
 
5.76±0.314
871.274±
5.81± 0.173
865±1.549
5.63±0.179
864 ±2.021
 Cycle 2
(97.29%)
1.576 (98.00%)
(98.47%)
(97.74%)
(98.59%)
(98.85%)
 
5.62 ±0.372
852.560± 1.732
5.78± 0.196
861±1.598
5.60±0.247
859 ±2.564
 Cycle 3
(94.93%)
(95.90%)
(97.96%)
(97.28%)
(98.07%)
(98.28%)
Recovery (ng) after storage at room temp.
5.92 ± 0.141
888.974 ± 1.876
5.90± 0.161
885±1.948
5.71±0.209
874 ±2.375
 0 h
5.62± 0.198
832.231 ±
5.77± 0.293
829±1.321
5.37±0.901
821 ±1.967
 24 h
(94.93%)
1.451 (93.61%)
(97.79%)
(93.67%)
(94.04%)
(93.93%)
Recovery (ng) after storage in auto sampler
5.92 ± 0.141
888.974 ± 1.876
5.90± 0.161
885±1.948
5.71±0.209
874 ±2.375
 0 h
5.80± 0.219
872.136 ±
5.77± 0.293
858±1.973
5.56±0.214
854 ±3.057
 24 h (97.97%) 2.151 (98.10%) (97.79%) (96.95%) (97.37%) (97.71%)

[TableWrap ID: T4] Table 4 

Pharmacokinetic parameters (curcumin)


   
AUC 0-∞ (ng*hr/ml)
2650.9± 13.2
C max (ng/ml)
278.0± 18.6
T max (hr)
2.0
Half Life (hr.)
10.1±0.96
Clearance (L/hr)
46.125±2.39
Vd (L/kg)
502.06±23.2
MRT (hr.) 18.3±1.21


Article Categories:
  • Research Article


Previous Document:  Sequential photooxidation of a Pt(II) (diimine)cysteamine complex: intermolecular oxygen atom transf...
Next Document:  Cell Exclusion in Couette Flow: Evaluation Through Flow Visualization and Mechanical Forces.